{
    "accession": "ENCBS337FXX",
    "age": "42",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "NTR:0000502",
    "biosample_term_name": "activated CD8-positive, naive alpha-beta T cell",
    "biosample_type": "primary cell",
    "characterizations": [],
    "dbxrefs": [],
    "description": "",
    "documents": [],
    "donor": "ENCDO833KUM",
    "lab": "John Stamatoyannopoulos, UW",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "AllCells",
    "summary": "Homo sapiens male adult (42 years) activated CD8-positive, naive alpha-beta T primary cell treated with anti-CD3 and anti-CD28 coated beads for 24 hours, 50 U/mL Interleukin-2 for 24 hours, 100 ng/mL Interleukin-15 for 24 hours",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 24,
            "duration_units": "hour",
            "treatment_term_name": "anti-CD3 and anti-CD28 coated beads",
            "treatment_type": "antibody"
        },
        {
            "dbxrefs": [],
            "duration": 24,
            "duration_units": "hour",
            "treatment_term_id": "UniProtKB:P60568",
            "treatment_term_name": "Interleukin-2",
            "treatment_type": "protein"
        },
        {
            "dbxrefs": [],
            "duration": 24,
            "duration_units": "hour",
            "treatment_term_id": "UniProtKB:P40933",
            "treatment_term_name": "Interleukin-15",
            "treatment_type": "protein"
        }
    ]
}